Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke

Currently, there is increasing interest in human bone marrow stromal cells (hBMSCs) as regeneration therapy against cerebral stroke. The aim of the present study was to evaluate the feasibility and validity of hBMSC cultures with allogeneic platelet lysates (PLs). Platelet concentrates (PC) were har...

Full description

Saved in:
Bibliographic Details
Main Authors: Chengbo Tan (Author), Hideo Shichinohe (Author), Zifeng Wang (Author), Shuji Hamauchi (Author), Takeo Abumiya (Author), Naoki Nakayama (Author), Ken Kazumata (Author), Tsuneo Ito (Author), Kohsuke Kudo (Author), Shigeru Takamoto (Author), Kiyohiro Houkin (Author)
Format: Book
Published: Hindawi Limited, 2016-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6ae5e44d5f424efea9e20e3dba6694a0
042 |a dc 
100 1 0 |a Chengbo Tan  |e author 
700 1 0 |a Hideo Shichinohe  |e author 
700 1 0 |a Zifeng Wang  |e author 
700 1 0 |a Shuji Hamauchi  |e author 
700 1 0 |a Takeo Abumiya  |e author 
700 1 0 |a Naoki Nakayama  |e author 
700 1 0 |a Ken Kazumata  |e author 
700 1 0 |a Tsuneo Ito  |e author 
700 1 0 |a Kohsuke Kudo  |e author 
700 1 0 |a Shigeru Takamoto  |e author 
700 1 0 |a Kiyohiro Houkin  |e author 
245 0 0 |a Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke 
260 |b Hindawi Limited,   |c 2016-01-01T00:00:00Z. 
500 |a 1687-966X 
500 |a 1687-9678 
500 |a 10.1155/2016/6104780 
520 |a Currently, there is increasing interest in human bone marrow stromal cells (hBMSCs) as regeneration therapy against cerebral stroke. The aim of the present study was to evaluate the feasibility and validity of hBMSC cultures with allogeneic platelet lysates (PLs). Platelet concentrates (PC) were harvested from healthy volunteers and made into single donor-derived PL (sPL). The PL mixtures (mPL) were made from three different sPL. Some growth factors and platelet cell surface antigens were detected by enzyme-linked immunosorbent assay (ELISA). The hBMSCs cultured with 10% PL were analyzed for their proliferative potential, surface markers, and karyotypes. The cells were incubated with superparamagnetic iron oxide (SPIO) agents and injected into a pig brain. MRI and histological analysis were performed. Consequently, nine lots of sPL and three mPL were prepared. ELISA analysis showed that PL contained adequate growth factors and a particle of platelet surface antigens. Cell proliferation capacity of PLs was equivalent to or higher than that of fetal calf serum (FCS). No contradiction in cell surface markers and no chromosomal aberrations were found. The MRI detected the distribution of SPIO-labeled hBMSCs in the pig brain. In summary, the hBMSCs cultured with allogeneic PL are suitable for cell therapy against stroke. 
546 |a EN 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Stem Cells International, Vol 2016 (2016) 
787 0 |n http://dx.doi.org/10.1155/2016/6104780 
787 0 |n https://doaj.org/toc/1687-966X 
787 0 |n https://doaj.org/toc/1687-9678 
856 4 1 |u https://doaj.org/article/6ae5e44d5f424efea9e20e3dba6694a0  |z Connect to this object online.